278 related articles for article (PubMed ID: 24428293)
1. Background parenchymal enhancement at breast MR imaging: normal patterns, diagnostic challenges, and potential for false-positive and false-negative interpretation.
Giess CS; Yeh ED; Raza S; Birdwell RL
Radiographics; 2014; 34(1):234-47. PubMed ID: 24428293
[TBL] [Abstract][Full Text] [Related]
2. Patterns of nonmasslike enhancement at screening breast MR imaging of high-risk premenopausal women.
Giess CS; Raza S; Birdwell RL
Radiographics; 2013; 33(5):1343-60. PubMed ID: 24025928
[TBL] [Abstract][Full Text] [Related]
3. Effect of Background Parenchymal Enhancement on Breast MR Imaging Interpretive Performance in Community-based Practices.
Ray KM; Kerlikowske K; Lobach IV; Hofmann MB; Greenwood HI; Arasu VA; Hylton NM; Joe BN
Radiology; 2018 Mar; 286(3):822-829. PubMed ID: 29072981
[TBL] [Abstract][Full Text] [Related]
4. Effective factors to raise diagnostic performance of breast MRI for diagnosing pathologic complete response in breast cancer patients after neoadjuvant chemotherapy.
Choi BB; Kim SH
Acta Radiol; 2015 Jul; 56(7):790-7. PubMed ID: 24951616
[TBL] [Abstract][Full Text] [Related]
5. Effect of background parenchymal enhancement on breast cancer detection with magnetic resonance imaging.
Telegrafo M; Rella L; Stabile Ianora AA; Angelelli G; Moschetta M
Diagn Interv Imaging; 2016 Mar; 97(3):315-20. PubMed ID: 26970658
[TBL] [Abstract][Full Text] [Related]
6. Effect of aromatase inhibitors on background parenchymal enhancement and amount of fibroglandular tissue at breast MR imaging.
King V; Goldfarb SB; Brooks JD; Sung JS; Nulsen BF; Jozefara JE; Pike MC; Dickler MN; Morris EA
Radiology; 2012 Sep; 264(3):670-8. PubMed ID: 22771878
[TBL] [Abstract][Full Text] [Related]
7. Inter- and intrareader agreement for categorization of background parenchymal enhancement at baseline and after training.
Melsaether A; McDermott M; Gupta D; Pysarenko K; Shaylor SD; Moy L
AJR Am J Roentgenol; 2014 Jul; 203(1):209-15. PubMed ID: 24951217
[TBL] [Abstract][Full Text] [Related]
8. Breast MRI background parenchymal enhancement (BPE) correlates with the risk of breast cancer.
Telegrafo M; Rella L; Stabile Ianora AA; Angelelli G; Moschetta M
Magn Reson Imaging; 2016 Feb; 34(2):173-6. PubMed ID: 26597834
[TBL] [Abstract][Full Text] [Related]
9. Enhanced mass on contrast-enhanced breast MR imaging: Lesion characterization using combination of dynamic contrast-enhanced and diffusion-weighted MR images.
Yabuuchi H; Matsuo Y; Okafuji T; Kamitani T; Soeda H; Setoguchi T; Sakai S; Hatakenaka M; Kubo M; Sadanaga N; Yamamoto H; Honda H
J Magn Reson Imaging; 2008 Nov; 28(5):1157-65. PubMed ID: 18972357
[TBL] [Abstract][Full Text] [Related]
10. Effect of Background Parenchymal Enhancement on Pre-Operative Breast Magnetic Resonance Imaging: How It Affects Interpretation and the Role of Second-Look Ultrasound in Patient Management.
Kim SY; Lee HS; Kim EK; Kim MJ; Moon HJ; Yoon JH
Ultrasound Med Biol; 2016 Dec; 42(12):2766-2774. PubMed ID: 27658753
[TBL] [Abstract][Full Text] [Related]
11. Comparison of Background Parenchymal Enhancement at Contrast-enhanced Spectral Mammography and Breast MR Imaging.
Sogani J; Morris EA; Kaplan JB; D'Alessio D; Goldman D; Moskowitz CS; Jochelson MS
Radiology; 2017 Jan; 282(1):63-73. PubMed ID: 27379544
[TBL] [Abstract][Full Text] [Related]
12. Background parenchymal enhancement at breast MR imaging and breast cancer risk.
King V; Brooks JD; Bernstein JL; Reiner AS; Pike MC; Morris EA
Radiology; 2011 Jul; 260(1):50-60. PubMed ID: 21493794
[TBL] [Abstract][Full Text] [Related]
13. Diagnostic Performance of and Breast Tissue Changes at Early Breast MR Imaging Surveillance in Women after Breast Conservation Therapy.
Kim EJ; Kang BJ; Kim SH; Youn IK; Baek JE; Lee HS
Radiology; 2017 Sep; 284(3):656-666. PubMed ID: 28419815
[TBL] [Abstract][Full Text] [Related]
14. Malignant spiculated breast masses: dynamic contrast enhanced MR (DCE-MR) imaging enhancement characteristics and histopathological correlation.
Gokalp G; Topal U; Yildirim N; Tolunay S
Eur J Radiol; 2012 Feb; 81(2):203-8. PubMed ID: 21236612
[TBL] [Abstract][Full Text] [Related]
15. Effect of the menstrual cycle on background parenchymal enhancement in breast MR imaging.
Kajihara M; Goto M; Hirayama Y; Okunishi S; Kaoku S; Konishi E; Shinkura N
Magn Reson Med Sci; 2013 Mar; 12(1):39-45. PubMed ID: 23474960
[TBL] [Abstract][Full Text] [Related]
16. Breast MR imaging: computer-aided evaluation program for discriminating benign from malignant lesions.
Williams TC; DeMartini WB; Partridge SC; Peacock S; Lehman CD
Radiology; 2007 Jul; 244(1):94-103. PubMed ID: 17507720
[TBL] [Abstract][Full Text] [Related]
17. Comparison of contrast enhancement and diffusion-weighted magnetic resonance imaging in healthy and cancerous breast tissue.
Cho GY; Moy L; Kim SG; Klautau Leite AP; Baete SH; Babb JS; Sodickson DK; Sigmund EE
Eur J Radiol; 2015 Oct; 84(10):1888-93. PubMed ID: 26220915
[TBL] [Abstract][Full Text] [Related]
18. Undiagnosed breast cancer at MR imaging: analysis of causes.
Pages EB; Millet I; Hoa D; Doyon FC; Taourel P
Radiology; 2012 Jul; 264(1):40-50. PubMed ID: 22523324
[TBL] [Abstract][Full Text] [Related]
19. Impact of tamoxifen on amount of fibroglandular tissue, background parenchymal enhancement, and cysts on breast magnetic resonance imaging.
King V; Kaplan J; Pike MC; Liberman L; David Dershaw D; Lee CH; Brooks JD; Morris EA
Breast J; 2012; 18(6):527-34. PubMed ID: 23002953
[TBL] [Abstract][Full Text] [Related]
20. Effects of gadobutrol on background parenchymal enhancement and differential diagnosis between benign and malignant lesions in dynamic magnetic resonance imaging of the breast.
Tozaki M; Yabuuchi H; Goto M; Sasaki M; Kubota K; Nakahara H
Breast Cancer; 2021 Jul; 28(4):927-936. PubMed ID: 33625722
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
